Compare ETFs: SURI
SURI
Comparison
Average Return
Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
---|---|---|---|---|---|
SURI | -1.02% | -22.15% | - | - | -7.60% |
Top 25 Holdings
SURI - Simplify Propel Opportunities ETF | |||
---|---|---|---|
No. | Symbol | Name | Weight |
1 | PAGP | Plains GP Holdings, L.P. | 35.45% |
2 | Cash | Cash | 20.67% |
3 | AKRO | Akero Therapeutics, Inc. | 11.03% |
4 | ABEO | Abeona Therapeutics Inc. | 5.43% |
5 | PHAT | Phathom Pharmaceuticals, Inc. | 4.64% |
6 | TELSAT.6.5 10.15.27 144A | TELSAT 6 1/2 10/15/27 Corp | 3.80% |
7 | DCTH | Delcath Systems, Inc. | 2.87% |
8 | TELSAT.5.625 12.06.26 144A | TELSAT 5 5/8 12/06/26 Corp | 2.65% |
9 | APLT | Applied Therapeutics, Inc. | 2.55% |
10 | MIST | Milestone Pharmaceuticals Inc. | 2.48% |
11 | TCRX | TScan Therapeutics, Inc. | 2.43% |
12 | ZVRA | Zevra Therapeutics, Inc. | 2.00% |
13 | ACHV | Achieve Life Sciences, Inc. | 1.15% |
14 | EPA: MAAT | MaaT Pharma SA | 0.87% |
15 | EIGRQ | Eiger BioPharmaceuticals, Inc. | 0.67% |
16 | ATHA | Athira Pharma, Inc. | 0.67% |
17 | CAPR | Capricor Therapeutics, Inc. | 0.64% |
18 | n/a | CONTRA CHINOOK THERAPE + NPV | 0.00% |
19 | n/a | n/a | n/a |
20 | n/a | n/a | n/a |
21 | n/a | n/a | n/a |
22 | n/a | n/a | n/a |
23 | n/a | n/a | n/a |
24 | n/a | n/a | n/a |
25 | n/a | n/a | n/a |
View SURI holdings |